NEU 1.08% $15.11 neuren pharmaceuticals limited

Competitors to Daybue, page-12

  1. 592 Posts.
    lightbulb Created with Sketch. 315
    Competition closing update:

    Taisha - 26% Neurogenic -24%

    Considerations: Rett Syndrome behind us (and Acadia) desert, Phelan Mc Dermid behind us desert, Pitt Hopkins behind us desert!!!

    I think this is enough, go Neuren!!!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.